8-K

Company

X4 Pharmaceuticals, Inc

Filed

December 20, 2018

Period of Report

December 12, 2018

Accession Number

0001193125-18-354676

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →